Compile Data Set for Download or QSAR
Report error Found 1404 of affinity data for UniProtKB/TrEMBL: Q92633
TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654058((R)-1-(3-fluorophenyl)ethyl (1-methyl-4-(4-(2,2,2-...)
Affinity DataEC50:  6.52E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654059(Preparation of [(1R)-1-(2-chloro-3-pyridyl)ethyl] ...)
Affinity DataEC50:  953nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654060(US11912686, Compound 3)
Affinity DataEC50:  1.00E+4nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654061(US11912686, Compound 4)
Affinity DataEC50:  1.00E+4nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654062(Preparation of [(1R)-1-(2-chloro-3-pyridyl)ethyl] ...)
Affinity DataEC50:  1.51E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654063(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl (...)
Affinity DataEC50:  1.86E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654064(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl (...)
Affinity DataEC50:  315nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654065(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl (...)
Affinity DataEC50:  154nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654066(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl (...)
Affinity DataEC50:  2.70E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654067(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl (...)
Affinity DataEC50:  1.02E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654068(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl(4...)
Affinity DataEC50:  731nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654069(Preparation of 1-(5-bromo-2-fluoropyridin-3-yl)eth...)
Affinity DataEC50:  541nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654070(Preparation of 1-(5-bromo-2-chloropyridin-3-yl)eth...)
Affinity DataEC50:  148nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654071(Preparation of (R)-1-(5-chloro-2-fluoropyridin-3-y...)
Affinity DataEC50:  1.20E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654072(Preparation of (R)-1-(2-chloro-5-fluoropyridin-3-y...)
Affinity DataEC50:  452nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654073(Preparation of (R)-1-(2-chloropyridin-3-4)ethyl (4...)
Affinity DataEC50:  2.19E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654074(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl(4...)
Affinity DataEC50:  29.3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654075(Preparation of (S)-2-fluoro-1-phenylethyl (4-(4-((...)
Affinity DataEC50:  1.13E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654076(Preparation of (S)-2-fluoro-1-(3-fluorophenyl)ethy...)
Affinity DataEC50:  276nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654077(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl(4...)
Affinity DataEC50:  39.6nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654078(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl(4...)
Affinity DataEC50:  43.4nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654079(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl (...)
Affinity DataEC50:  1.11E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654080(Preparation of (S)-2-fluoro-1-(3-fluorophenyl)ethy...)
Affinity DataEC50:  2.27E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654081(Preparation of 1-(2-fluoro-5-methylpyridin-4-yl)et...)
Affinity DataEC50:  587nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654082(Preparation of 1-(2-fluoro-5-methylpyridin-4-yl)et...)
Affinity DataEC50:  1.28E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654083(Preparation of (R)-1-(2,5-difluoropyridin-3-yl)eth...)
Affinity DataEC50:  29.1nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654084(US11912686, Compound 29)
Affinity DataEC50:  261nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654085(US11912686, Compound 30)
Affinity DataEC50:  516nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654086(US11912686, Compound 31)
Affinity DataEC50:  2.33E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654087(US11912686, Compound 32)
Affinity DataEC50:  799nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654088(US11912686, Compound 33)
Affinity DataEC50:  1.02E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654089(US11912686, Compound 34)
Affinity DataEC50:  429nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654090(US11912686, Compound 35)
Affinity DataEC50:  103nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654091(US11912686, Compound 36)
Affinity DataEC50:  112nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654092(US11912686, Compound 37)
Affinity DataEC50:  54.6nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654093(Preparation of (R)-1-(2-chloropyridin-3-yl)ethyl (...)
Affinity DataEC50:  1.00E+4nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654094(US11912686, Compound 168 | US11912686, Compound 39)
Affinity DataEC50:  50.8nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654095(US11912686, Compound 40)
Affinity DataEC50:  75.2nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654096(US11912686, Compound 41)
Affinity DataEC50:  38.1nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654097(US11912686, Compound 42)
Affinity DataEC50:  201nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654098(US11912686, Compound 43)
Affinity DataEC50:  497nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654099(US11912686, Compound 44)
Affinity DataEC50:  165nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654100(US11912686, Compound 45)
Affinity DataEC50:  40.8nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654101(US11912686, Compound 46)
Affinity DataEC50:  29.7nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654102(US11912686, Compound 47)
Affinity DataEC50:  19.1nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654103(US11912686, Compound 48)
Affinity DataEC50:  22.8nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654104(US11912686, Compound 49)
Affinity DataEC50:  353nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654105(US11912686, Compound 50)
Affinity DataEC50:  1.76E+3nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654106(US11912686, Compound 51)
Affinity DataEC50:  88.7nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Gilead Sciences

US Patent
LigandPNGBDBM654107(US11912686, Compound 52)
Affinity DataEC50:  622nMAssay Description:CHO-K1 EDG2 cells (DiscoverX cat #93-0644C2) expressing human LPAR1 (NM_001401.3) were seeded in a total volume of 25 μL of Dulbecco's Modif...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2024
Entry Details
US Patent

Displayed 1 to 50 (of 1404 total ) | Next | Last >>
Jump to: